16-89112123-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001243279.3(ACSF3):c.854C>T(p.Pro285Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0152 in 1,112,452 control chromosomes in the GnomAD database, including 142 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.087 ( 19 hom., cov: 0)
Exomes 𝑓: 0.014 ( 123 hom. )
Consequence
ACSF3
NM_001243279.3 missense
NM_001243279.3 missense
Scores
1
6
11
Clinical Significance
Conservation
PhyloP100: 5.17
Genes affected
ACSF3 (HGNC:27288): (acyl-CoA synthetase family member 3) This gene encodes a member of the acyl-CoA synthetase family of enzymes that activate fatty acids by catalyzing the formation of a thioester linkage between fatty acids and coenzyme A. The encoded protein is localized to mitochondria, has high specificity for malonate and methylmalonate and possesses malonyl-CoA synthetase activity. Mutations in this gene are a cause of combined malonic and methylmalonic aciduria. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Sep 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0010101199).
BP6
Variant 16-89112123-C-T is Benign according to our data. Variant chr16-89112123-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 381877.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-89112123-C-T is described in Lovd as [Benign]. Variant chr16-89112123-C-T is described in Lovd as [Likely_benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.135 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0873 AC: 1397AN: 16008Hom.: 19 Cov.: 0
GnomAD3 genomes
AF:
AC:
1397
AN:
16008
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00996 AC: 2326AN: 233436Hom.: 40 AF XY: 0.00972 AC XY: 1231AN XY: 126676
GnomAD3 exomes
AF:
AC:
2326
AN:
233436
Hom.:
AF XY:
AC XY:
1231
AN XY:
126676
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0141 AC: 15503AN: 1096394Hom.: 123 Cov.: 41 AF XY: 0.0143 AC XY: 7690AN XY: 536310
GnomAD4 exome
AF:
AC:
15503
AN:
1096394
Hom.:
Cov.:
41
AF XY:
AC XY:
7690
AN XY:
536310
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0870 AC: 1397AN: 16058Hom.: 19 Cov.: 0 AF XY: 0.0955 AC XY: 767AN XY: 8028
GnomAD4 genome
AF:
AC:
1397
AN:
16058
Hom.:
Cov.:
0
AF XY:
AC XY:
767
AN XY:
8028
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
35
ALSPAC
AF:
AC:
46
ESP6500AA
AF:
AC:
9
ESP6500EA
AF:
AC:
93
ExAC
AF:
AC:
1062
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 08, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Dec 10, 2021 | - - |
Combined malonic and methylmalonic acidemia Benign:3
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Jun 02, 2020 | - - |
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Mar 07, 2022 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 03, 2025 | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2024 | ACSF3: BP4, BS1, BS2 - |
Likely benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;T;T;.;T;T;.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;.;D;D;.;D;D;D
MetaRNN
Benign
T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;L;L;.;L;.;.;.
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D;.;D;D;D;D;D
REVEL
Benign
Sift
Uncertain
D;D;.;D;D;D;T;D
Sift4G
Uncertain
D;D;D;T;D;D;D;D
Polyphen
0.61
.;P;P;.;P;.;.;.
Vest4
0.69, 0.74
MPC
0.30
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at